Back to Journals » Drug Design, Development and Therapy » Volume 13

Original Research

Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway

       
Total article views   HTML views PDF downloads Totals
15,298 Dovepress* 9,429+ 1,321 10,750
PubMed Central* 5,869 423 6,292
Totals 15,298 1,744 17,042
*Since 4 February 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar